Royal Bank of Canada’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Buy |
774,474
+771,315
| +24,416% | +$729K | ﹤0.01% | 3853 |
|
|
2025
Q1 | $1K | Sell |
3,159
-6,752
| -68% | -$2.14K | ﹤0.01% | 6293 |
|
|
2024
Q4 | $7K | Sell |
9,911
-1,488
| -13% | -$1.05K | ﹤0.01% | 5957 |
|
|
2024
Q3 | $18K | Buy |
11,399
+561
| +5% | +$886 | ﹤0.01% | 5671 |
|
|
2024
Q2 | $18K | Buy |
10,838
+8,670
| +400% | +$14.4K | ﹤0.01% | 5721 |
|
|
2024
Q1 | $5K | Sell |
2,168
-26,917
| -93% | -$62.1K | ﹤0.01% | 5998 |
|
|
2023
Q4 | $44K | Buy |
29,085
+15,307
| +111% | +$23.2K | ﹤0.01% | 5517 |
|
|
2023
Q3 | $15K | Buy |
13,778
+5,871
| +74% | +$6.39K | ﹤0.01% | 5784 |
|
|
2023
Q2 | $18K | Buy |
7,907
+3,247
| +70% | +$7.39K | ﹤0.01% | 5809 |
|
|
2023
Q1 | $11K | Sell |
4,660
-7,960
| -63% | -$18.8K | ﹤0.01% | 5878 |
|
|
2022
Q4 | $24K | Buy |
12,620
+11,585
| +1,119% | +$22K | ﹤0.01% | 5761 |
|
|
2022
Q3 | $2K | Buy |
1,035
+115
| +13% | +$222 | ﹤0.01% | 6544 |
|
|
2022
Q2 | $2K | Sell |
920
-3,891
| -81% | -$8.46K | ﹤0.01% | 6498 |
|
|
2022
Q1 | $10K | Sell |
4,811
-8,975
| -65% | -$18.7K | ﹤0.01% | 6457 |
|
|
2021
Q4 | $54K | Buy |
13,786
+7,109
| +106% | +$27.8K | ﹤0.01% | 5805 |
|
|
2021
Q3 | $31K | Buy |
6,677
+1,492
| +29% | +$6.93K | ﹤0.01% | 5922 |
|
|
2021
Q2 | $23K | Buy |
5,185
+533
| +11% | +$2.36K | ﹤0.01% | 5995 |
|
|
2021
Q1 | $27K | Buy |
4,652
+3,440
| +284% | +$20K | ﹤0.01% | 5752 |
|
|
2020
Q4 | $4K | Sell |
1,212
-443
| -27% | -$1.46K | ﹤0.01% | 6175 |
|
|
2020
Q3 | $2K | Buy |
1,655
+363
| +28% | +$439 | ﹤0.01% | 5828 |
|
|
2020
Q2 | $3K | Sell |
1,292
-2,301
| -64% | -$5.34K | ﹤0.01% | 5708 |
|
|
2020
Q1 | $7K | Buy |
3,593
+2,998
| +504% | +$5.84K | ﹤0.01% | 5440 |
|
|
2019
Q4 | $3K | Sell |
595
-183
| -24% | -$923 | ﹤0.01% | 5882 |
|
|
2019
Q3 | $2K | Buy |
778
+39
| +5% | +$100 | ﹤0.01% | 5626 |
|
|
2019
Q2 | $5K | Sell |
739
-20
| -3% | -$135 | ﹤0.01% | 5399 |
|
|
2019
Q1 | $4K | Buy |
759
+450
| +146% | +$2.37K | ﹤0.01% | 5368 |
|
|
2018
Q4 | $2K | Sell |
309
-896
| -74% | -$5.8K | ﹤0.01% | 5549 |
|
|
2018
Q3 | $13K | Buy |
1,205
+735
| +156% | +$7.93K | ﹤0.01% | 5269 |
|
|
2018
Q2 | $6K | Sell |
470
-716
| -60% | -$9.14K | ﹤0.01% | 5400 |
|
|
2018
Q1 | $10K | Buy |
1,186
+526
| +80% | +$4.44K | ﹤0.01% | 5105 |
|
|
2017
Q4 | $7K | Sell |
660
-4,095
| -86% | -$43.4K | ﹤0.01% | 5228 |
|
|
2017
Q3 | $58K | Buy |
4,755
+4,398
| +1,232% | +$53.6K | ﹤0.01% | 4594 |
|
|
2017
Q2 | $6K | Sell |
357
-1,240
| -78% | -$20.8K | ﹤0.01% | 5229 |
|
|
2017
Q1 | $24K | Buy |
1,597
+118
| +8% | +$1.77K | ﹤0.01% | 4861 |
|
|
2016
Q4 | $20K | Sell |
1,479
-16,207
| -92% | -$219K | ﹤0.01% | 5006 |
|
|
2016
Q3 | $319K | Sell |
17,686
-7,488
| -30% | -$135K | ﹤0.01% | 3392 |
|
|
2016
Q2 | $362K | Sell |
25,174
-6,712
| -21% | -$96.5K | ﹤0.01% | 3323 |
|
|
2016
Q1 | $381K | Buy |
31,886
+31,101
| +3,962% | +$372K | ﹤0.01% | 3263 |
|
|
2015
Q4 | $11K | Sell |
785
-1,608
| -67% | -$22.5K | ﹤0.01% | 5170 |
|
|
2015
Q3 | $26K | Sell |
2,393
-854
| -26% | -$9.28K | ﹤0.01% | 4861 |
|
|
2015
Q2 | $26K | Buy |
3,247
+1,661
| +105% | +$13.3K | ﹤0.01% | 5074 |
|
|
2015
Q1 | $10K | Buy |
1,586
+435
| +38% | +$2.74K | ﹤0.01% | 5119 |
|
|
2014
Q4 | $7K | Buy |
1,151
+17
| +1% | +$103 | ﹤0.01% | 5122 |
|
|
2014
Q3 | $11K | Buy |
1,134
+333
| +42% | +$3.23K | ﹤0.01% | 4897 |
|
|
2014
Q2 | $9K | Buy |
801
+107
| +15% | +$1.2K | ﹤0.01% | 4929 |
|
|
2014
Q1 | $9K | Sell |
694
-505
| -42% | -$6.55K | ﹤0.01% | 4915 |
|
|
2013
Q4 | $15K | Sell |
1,199
-675
| -36% | -$8.45K | ﹤0.01% | 4723 |
|
|
2013
Q3 | $31K | Buy |
1,874
+1,781
| +1,915% | +$29.5K | ﹤0.01% | 4450 |
|
|
2013
Q2 | $1K | Buy |
+93
| New | +$1K | ﹤0.01% | 5112 |
|